|
Volumn 75, Issue , 2014, Pages 438-447
|
Design and synthesis of thiazole derivatives as potent FabH inhibitors with antibacterial activity
|
Author keywords
3D QSAR; Antibacterial; FabH; Molecular docking; Thiazole derivatives
|
Indexed keywords
2 (3 BROMOPHENYL) N (4 (4 BROMOPHENYL)THIAZOL 2 YL)ACETAMIDE;
2 (3 BROMOPHENYL) N (4 PHENYLTHIAZOL 2 YL)ACETAMIDE;
2 (3 CHLOROPHENYL) N (4 PHENYLTHIAZOL 2 YL)ACETAMIDE;
2 (3 METHOXYPHENYL) N (4 PHENYLTHIAZOL 2 YL)ACETAMIDE;
2 (3,4 DIETHOXYPHENYL) N (4 PHENYLTHIAZOL 2 YL)ACETAMIDE;
2 (4 BROMOPHENYL) N (4 (4 BROMOPHENYL)THIAZOL 2 YL)ACETAMIDE;
2 (4 BROMOPHENYL) N (4 PHENYLTHIAZOL 2 YL)ACETAMIDE;
2 (4 CHLOROPHENYL) N (4 PHENYLTHIAZOL 2 YL)ACETAMIDE;
2 (4 FLUOROPHENYL) N (4 PHENYLTHIAZOL 2 YL)ACETAMIDE;
2 PHENYL N (4 PHENYLTHIAZOL 2 YL)ACETAMIDE;
ACETAMIDE DERIVATIVE;
ACYLTRANSFERASE INHIBITOR;
AMINE;
ANTIINFECTIVE AGENT;
AROMATIC CARBOXYLIC ACID;
N (4 (4 BROMOPHENYL)THIAZOL 2 YL) 1 NAPHTHAMIDE;
N (4 (4 BROMOPHENYL)THIAZOL 2 YL) 2 (3 CHLOROPHENYL)ACETAMIDE;
N (4 (4 BROMOPHENYL)THIAZOL 2 YL) 2 (3 METHOXYPHENYL)ACETAMIDE;
N (4 (4 BROMOPHENYL)THIAZOL 2 YL) 2 (3,4 DIETHOXYPHENYL)ACETAMIDE;
N (4 (4 BROMOPHENYL)THIAZOL 2 YL) 2 (4 CHLOROPHENYL)ACETAMIDE;
N (4 (4 BROMOPHENYL)THIAZOL 2 YL) 2 (4 FLUOROPHENYL)ACETAMIDE;
N (4 (4 BROMOPHENYL)THIAZOL 2 YL) 2 NAPHTHAMIDE;
N (4 (4 BROMOPHENYL)THIAZOL 2 YL) 2 PHENYLACETAMIDE;
N (4 (4 BROMOPHENYL)THIAZOL 2 YL)BENZAMIDE;
N (4 (4 BROMOPHENYL)THIAZOL 2 YL)MORPHOLINE 4 CARBOXAMIDE;
N (4 PHENYLTHIAZOL 2 YL) 1 NAPHTHAMIDE;
N (4 PHENYLTHIAZOL 2 YL) 2 NAPHTHAMIDE;
N (4 PHENYLTHIAZOL 2 YL)BENZAMIDE;
N (4 PHENYLTHIAZOL 2 YL)MORPHOLINE 4 CARBOXAMIDE;
THIAZOLE DERIVATIVE;
UNCLASSIFIED DRUG;
ANTIBACTERIAL ACTIVITY;
ARTICLE;
BACILLUS SUBTILIS;
CHEMICAL BOND;
DRUG DESIGN;
DRUG SYNTHESIS;
ESCHERICHIA COLI;
IC 50;
MINIMUM INHIBITORY CONCENTRATION;
MOLECULAR DOCKING;
MOLECULAR MODEL;
MTT ASSAY;
NONHUMAN;
PSEUDOMONAS AERUGINOSA;
QUANTITATIVE STRUCTURE ACTIVITY RELATION;
SIMULATION;
STAPHYLOCOCCUS AUREUS;
3D-QSAR;
ANTIBACTERIAL;
FABH;
MOLECULAR DOCKING;
THIAZOLE DERIVATIVES;
ACETYLTRANSFERASES;
ANTI-BACTERIAL AGENTS;
BACTERIA;
BACTERIAL INFECTIONS;
DRUG DESIGN;
ESCHERICHIA COLI;
ESCHERICHIA COLI INFECTIONS;
ESCHERICHIA COLI PROTEINS;
FATTY ACID SYNTHASE, TYPE II;
HUMANS;
MOLECULAR DOCKING SIMULATION;
STRUCTURE-ACTIVITY RELATIONSHIP;
THIAZOLES;
|
EID: 84896735603
PISSN: 02235234
EISSN: 17683254
Source Type: Journal
DOI: 10.1016/j.ejmech.2013.11.020 Document Type: Article |
Times cited : (50)
|
References (27)
|